Regarding its mechanism of action, UBE3C induces the proteasomal degradation of Annexin A7 [51]: this protein is believed to act as a tumor suppressor in GBM via attenuation of the epidermal growth factor receptor (EGFR) signaling [52]. This evidence concerns the gene UBE3C and neoplasm.